Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 02, 2026 06:00 ET | Source: SOLV Energy, Inc.

SOLV Energy Announces Launch of Initial Public Offering

SAN DIEGO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- SOLV Energy, Inc. (“SOLV” or the “Company”), a leading provider of infrastructure services to the power industry, today announced that it has launched...
February 02, 2026 04:00 ET | Source: Patria Investments Limited

Patria Investments Announces Acquisition of WP Global Partners

The acquisition enhances Patria’s scale in a strategic market, strengthening its middle-market primaries and co-investment private equity capabilities in the U.S., broadening GP relationships and...
February 02, 2026 04:00 ET | Source: Kanzhun Limited

BOSS Zhipin Continues Executing Share Repurchase Program

BEIJING, Feb. 02, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED (“BOSS Zhipin” or the “Company”) (Nasdaq: BZ; HK: 2076) today announced the continued execution of its share repurchase program, utilizing...
February 02, 2026 03:00 ET | Source: Alvotech

Alvotech gerir samninga um markaðssetningu á fyrirhuguðum hliðstæðum í Kanada, Ástralíu og Nýja-Sjálandi

REYKJAVÍK (2. FEBRÚAR 2026) - Alvotech (NASDAQ: ALVO, ALVO SDB) tilkynnti í dag að samningar hefðu náðst við svissneska lyfjafyrirtækið Sandoz, um sölu og markaðssetningu í Kanada, Ástralíu og...
February 02, 2026 03:00 ET | Source: Alvotech

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

REYKJAVIK, ICELAND (February 2, 2026) — Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today...
February 02, 2026 03:00 ET | Source: Alvotech

Alvotech enters supply and commercialization agreements for Canada and Australia & New Zealand covering multiple biosimilar candidates

REYKJAVIK, Iceland, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients...
February 02, 2026 03:00 ET | Source: 21Shares

21shares Appoints Stephen Coltman as Head of Macro to Strengthen Investment Team

2 February 2026, London: 21shares, a leading global provider of crypto ETPs, is pleased to announce the appointment of Stephen Coltman as Head of Macro, effective at the beginning of February. This...
February 02, 2026 01:00 ET | Source: Molecular Partners

Molecular Partners Announces Presentation of First Imaging and Dosimetry Data of DLL3-Targeting Radiotherapy MP0712 in Patients at TWC 2026

Specific tumor accumulation and attractive biodistribution highly supportive of MP0712 clinical development for treatment of DLL3-expressing cancersDosimetry data highlight Radio-DARPins as vector for...
February 01, 2026 15:17 ET | Source: Pharming Group N.V.

Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS

Pharming Group received an FDA Complete Response Letter for its sNDA for Joenja® (leniolisib) in children aged 4–11 with APDS
January 31, 2026 21:00 ET | Source: Li Auto Inc.

Li Auto Inc. January 2026 Delivery Update

BEIJING, China, Feb. 01, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered...